Second [qnco]
Line [spco]
Agent [chvf]
glycemia [carb]
Type 2 Diabetes [dsyn]
Agent [chvf]
Metformin [orch, phsu]
Accepted [qlco]
Line [spco]
Agent [chvf]
In [qnco]
treatment [ftcn]
Type 2 Diabetes [dsyn]
Insufficient [qlco]
Extensive [qlco]
debate [acty]
Best [qlco]
Second [qnco]
Line [spco]
Agent [chvf]
Benefits [qnco]
Treatment Regimen [topp]
Effectiveness [qlco]
Quality [qlco]
Life [idcn]
Cost [qnco]
Research Design [resa]
Population Control [ocdi]
Based [ftcn]
glycemia [carb]
simulate [bodm]
Natural [ftcn]
Variation [qlco]
HbA [aapp, bacs]
progression [patf]
U S [geoa]
Data Set [inpr]
Insured [inpr]
Diagnosed [fndg]
Type 2 Diabetes [dsyn]
Compared [acty]
treatment [ftcn]
Metformin [orch, phsu]
Sulfonylurea [orch, phsu]
Dipeptidyl Peptidase 4 Inhibitor [phsu]
Glucagon-like Peptide-1 Receptor Agonist [phsu]
Insulin [aapp, horm, phsu]
Measure [qnco]
included [ftcn]
Life [idcn]
Quality-Adjusted Life Years [tmco]
Insulin [aapp, horm, phsu]
Dependence [menp]
Expected [idcn]
Medication [phsu]
Cost [qnco]
QALY [tmco]
Diabetes Complication [patf]
ischaemic heart disease [dsyn]
Myocardial Infarction [dsyn]
Congestive heart failure [dsyn]
Stroke [dsyn]
Blindness [dsyn]
Renal Failure [dsyn]
Amputation [topp]
regimens [inpr]
Life [idcn]
Quality-Adjusted Life Years [tmco]
glycemia [carb]
Goal [inpr]
Regimen [topp]
Sulfonylurea [orch, phsu]
Cost [qnco]
QALY [tmco]
Longest [qlco]
Insulin [aapp, horm, phsu]
Dependence [menp]
HbA [aapp, bacs]
Goal [inpr]
MMOLE [qnco]
Mole [neop]
Quality-Adjusted Life Years [tmco]
Compared [acty]
Goal [inpr]
MMOLE [qnco]
Mole [neop]
regimens [inpr]
Sulfonylurea [orch, phsu]
Second Line Therapy [topp]
Type 2 Diabetes [dsyn]
Generated [acty]
glycemia [carb]
Quality-Adjusted Life Years [tmco]
Agent [chvf]
Cost [qnco]
HbA [aapp, bacs]
Diabetes Complications [patf]
Decision [menp]
Tool [mnob]
treatment options [topp]
